Title: |
Recurrence Rates in Patients with HER2+ Breast Cancer Who Achieved a Pathological Complete Response after Neoadjuvant Pertuzumab plus Trastuzumab Followed by Adjuvant Trastuzumab: A Real-World Evidence Study |
Dateline: |
2021-03-01
DisplayDateline
|
Byline: |
O'Shaughnessy J, Robert N, Annavarapu S, Zhou J, Sussell J, Cheng A, Fung A |
Publication Title: |
Breast Cancer Research and Treatment
|
CTA Link: |
https://pubmed.ncbi.nlm.nih.gov/33649981/ |
CTA Text: |
Read More |
Filter(s):* This
creates the tags that filter the listing page by specific taxonomies that display to the right of the
main content and read more link.
|
-
|